Fredag 25 April | 17:42:11 Europe / Stockholm

Prenumeration

2025-04-25 09:45:00

Redeye returns with a more in-depth take on the Q1 report. In contrast to the Q4 report, Fx fluctuations impacted EBIT negatively – more important case-factors, such as US CERAMENT G sales, were in line with expectations. We slightly decrease our fair value range.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/